secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001822479-24-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health reports 2023 revenue $1.05B (+4.5%); net income $51M; 2024 outlook 4-6% growth
--------------------------------------------------------------------------------

- 2023 net revenues $1.05B (+4.5% YoY); net income $51M vs loss of $234M in 2022.
- Q4 net revenues $310M (+23.3% YoY); net income $39M vs loss of $320M (incl $408M legal reserve).
- 2023 Adjusted EBITDA $528M (+4.3%); Adjusted EPS $0.81, down $0.15 from 2022.
- Sterigenics segment net revenues $667M (+6.5%); segment income $362M (+6.8%).
- Full-year 2024 guidance: 4.0%-6.0% growth for Net Revenues and Adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000008/0001822479-24-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000008/shc-20240227.htm
  HTML page:      https://secwatch.observer/filing/0001822479-24-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer